Acta Pharmaceutica Sinica B,
Journal Year:
2022,
Volume and Issue:
13(5), P. 1828 - 1846
Published: Sept. 23, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
has
been
a
major
health
burden
in
the
world.
So
far,
many
strategies
have
investigated
to
control
spread
of
COVID-19,
including
social
distancing,
disinfection
protocols,
vaccines,
and
antiviral
treatments.
Despite
significant
achievement,
due
constantly
emerging
new
variants,
COVID-19
is
still
great
challenge
global
healthcare
system.
It
an
urgent
demand
for
development
therapeutics
technologies
containing
wild
SARS-CoV-2.
Inhaled
administration
useful
treatment
lung
diseases,
enables
drugs
reach
site
action
directly
with
benefits
decreased
dose,
improved
safety,
enhanced
patient
compliance.
Nanotechnology
extensively
applied
prevention
COVID-19.
In
this
review,
inhaled
nanomedicines
antibodies,
as
well
intranasal
nanodrugs,
are
summarized.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(4), P. 2174 - 2174
Published: Feb. 11, 2024
The
contagiousness
of
SARS-CoV-2
β-coronavirus
is
determined
by
the
virus–receptor
electrostatic
association
its
positively
charged
spike
(S)
protein
with
negatively
angiotensin
converting
enzyme-2
(ACE2
receptor)
epithelial
cells.
If
some
mutations
occur,
potential
on
surface
receptor-binding
domain
(RBD)
could
be
altered,
and
S-ACE2
become
stronger
or
weaker.
aim
current
research
to
investigate
whether
point
can
noticeably
alter
RBD
3D
stability
S1-subunit
S-protein.
For
this
purpose,
15
mutants
different
hydrophilicity
electric
charge
(positive,
negative,
uncharged)
substituted
substituting
amino
acid
residues,
located
at
S1-ACE2
interface,
are
selected,
structure
reconstructed
base
crystallographic
S-protein
wild-type
strain
sequence
unfolded
polypeptide
chain
mutants.
Then,
Gibbs
free
energy
folding,
isoelectric
point,
pH-dependent
computed
using
programs
for
electrostatics.
results
show
alterations
in
local
vicinity
mutant
residue,
which
influence
association.
This
approach
allows
prediction
relative
infectivity,
transmissibility,
(at
equal
social
immune
status)
new
reconstruction
calculation
potential.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(17), P. 10091 - 10091
Published: Sept. 3, 2022
The
receptor-binding
domain
(RBD)
is
the
essential
part
in
Spike-protein
(S-protein)
of
SARS-CoV-2
virus
that
directly
binds
to
human
ACE2
receptor,
making
it
a
key
target
for
many
vaccines
and
therapies.
Therefore,
any
mutations
at
this
could
affect
efficacy
these
treatments
as
well
viral-cell
entry
mechanism.
We
introduce
ab
initio
DFT-based
computational
study
mainly
focuses
on
two
parts:
(1)
Mutations
effects
both
Delta
Omicron
variants
RBD-SD1
domain.
(2)
Impact
RBD
structure
properties
RBD-ACE2
interface
system.
in-depth
analysis
based
novel
concept
amino
acid-amino
acid
bond
pair
units
(AABPU)
reveal
differences
between
and/or
its
corresponding
wild-type
strain
terms
role
played
by
non-local
interactions,
their
3D
shapes
sizes,
contribution
hydrogen
bonding
partial
charge
distributions.
Our
results
also
show
interaction
with
significantly
increased
acids
providing
information
implications
penetration
S-protein
into
ACE2,
thus
offering
possible
explanation
high
infectivity.
findings
enable
us
present,
more
conspicuous
atomic
level
detail,
effect
specific
may
help
predicting
mitigating
next
variant
concern.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 13, 2024
A
recombinant
lineage
of
the
SARS-CoV-2
Omicron
variant,
named
XBB,
appeared
in
late
2022
and
evolved
descendants
that
successively
swept
local
global
populations.
XBB
members
were
noted
for
their
improved
immune
evasion
transmissibility.
Here,
we
determine
cryo-EM
structures
XBB.1.5,
XBB.1.16,
EG.5
EG.5.1
spike
(S)
ectodomains
to
reveal
reinforced
3-RBD-down
receptor
inaccessible
closed
states
mediated
by
interprotomer
binding
domain
(RBD)
interactions
previously
observed
BA.1
BA.2.
Improved
XBB.1.5
XBB.1.16
RBD
stability
compensated
loss
caused
early
mutations,
while
F456L
substitution
reduced
stability.
S1
subunit
mutations
had
long-range
impacts
on
conformation
epitope
presentation
S2
subunit.
Our
results
continued
S
protein
evolution
via
simultaneous
optimization
multiple
parameters
including
stability,
evasion,
dramatic
effects
relatively
few
residue
substitutions
altering
conformational
landscape.
Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: May 30, 2023
Spike
glycoprotein
of
SARS-CoV-2
variants
plays
a
critical
role
in
infection
and
transmission
through
its
interaction
with
human
angiotensin
converting
enzyme
2
(hACE2)
receptors.
Prior
findings
using
molecular
docking
biomolecular
studies
reported
varied
on
the
difference
interactions
among
spike
hACE2
Hence,
it
is
prerequisite
to
understand
these
more
precise
manner.
To
this
end,
firstly,
we
performed
ELISA
trimeric
glycoproteins
including
Wuhan
Hu-1(Wild),
Delta,
C.1.2
Omicron.
Further,
study
specific
manner
by
mimicking
natural
infection,
developed
receptors
expressing
HEK-293T
cell
line,
evaluated
their
binding
efficiencies
competitive
D614G
pseudotyped
virus.
In
line
existing
findings,
observed
that
Omicron
had
higher
efficiency
compared
Delta
both
Cellular
models.
Intriguingly,
found
cellular
models
could
differentiate
subtle
differences
between
closely
related
Our
model
provides
method
evaluate
sub-lineages
Acta Pharmaceutica Sinica B,
Journal Year:
2022,
Volume and Issue:
13(5), P. 1828 - 1846
Published: Sept. 23, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
has
been
a
major
health
burden
in
the
world.
So
far,
many
strategies
have
investigated
to
control
spread
of
COVID-19,
including
social
distancing,
disinfection
protocols,
vaccines,
and
antiviral
treatments.
Despite
significant
achievement,
due
constantly
emerging
new
variants,
COVID-19
is
still
great
challenge
global
healthcare
system.
It
an
urgent
demand
for
development
therapeutics
technologies
containing
wild
SARS-CoV-2.
Inhaled
administration
useful
treatment
lung
diseases,
enables
drugs
reach
site
action
directly
with
benefits
decreased
dose,
improved
safety,
enhanced
patient
compliance.
Nanotechnology
extensively
applied
prevention
COVID-19.
In
this
review,
inhaled
nanomedicines
antibodies,
as
well
intranasal
nanodrugs,
are
summarized.